ChemoCentryx Income Statement
View: Annual
| Dec 06 | Dec 05 | Dec 04 | |
|---|---|---|---|
| Revenue | 8.1 | 12.2 | 6.7 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 27.2 | 30.2 | 17.9 |
| Depreciation & Amortization | 0.7 | 0.7 | 0.5 |
| Operating Income | (19.1) | (17.3) | (11.2) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 1.9 | 0.7 | 0.3 |
| Nonoperating Expenses | 0.1 | 0.0 | 0.1 |
| Income Before Taxes | (17.3) | (17.3) | (11.0) |
| Income Taxes | 0.0 | 0.0 | 0.0 |
| Net Income After Taxes | (17.3) | (17.3) | (11.0) |
| Continuing Operations | (17.3) | (17.3) | (11.0) |
| Discontinued Operations | 0.0 | 0.0 | 0.0 |
| Total Operations | (17.3) | (17.3) | (11.0) |
| Total Net Income | (17.3) | (17.3) | (11.0) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | -- | -- | -- |
| Dividends per Share | -- | -- | -- |
